MICHAEL J. KELLY,MARK E. LAYTON,MICHAEL E. LIQUORI,YOSHIO OGINO,YU ONOZAKI,PHILIP E. SANDERSON,JIABING WANG
申请号：
HK10102928.1
公开号：
HK1137758B
申请日:
2010.03.19
申请国别(地区):
HK
年份:
2014
代理人:
摘要：
The instant invention provides for substituted naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.
